Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program
1 other identifier
interventional
26
1 country
1
Brief Summary
The purpose of this study is to test feasibility and acceptability of a psycho-behavioral intervention on sleep in cancer patients and their partners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2021
CompletedFirst Posted
Study publicly available on registry
January 15, 2021
CompletedStudy Start
First participant enrolled
March 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2022
CompletedMarch 10, 2022
February 1, 2022
11 months
January 13, 2021
February 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of the intervention
Feasibility of the intervention will be reported as the percentage of participants who enroll and complete all the sessions of the study.
4 weeks
Acceptability of the intervention
Acceptability of the intervention will be reported as the percentage of participants who evaluated the intervention and the interventionist as "satisfactory" or better.
4 weeks
Secondary Outcomes (2)
Change in sleep disturbance
Baseline, 4 weeks
Change in quality of life
Baseline, 4 weeks
Study Arms (1)
MSOS Group
EXPERIMENTALThe participants in this group will receive the MSOS Intervention for 4 consecutive weeks.
Interventions
MSOS Program is a weekly one-hour Zoom session that focuses on psychoeducation on sleep health for both patients and their sleep partners.
Eligibility Criteria
You may qualify if:
- Patients:
- newly diagnosed with a gastrointestinal cancer (stage I to IV) 12 months or less prior to participating
- years or older
- able to speak/read English at the 5th grade level
- having a consistent partner who is involved in daily activities including sleep
- having 5 or greater score on the Pittsburgh Sleep Quality Index.
- Sleep partners:
- years or older
- able to speak/read English at the 5th grade level
- a partner of the patient who is involved in the patient's daily activities including sleep
- having similar circadian rhythm/sleep patterns with the patient
- having 5 or greater score on the Pittsburgh Sleep Quality Index.
You may not qualify if:
- Patients and their sleep partners:
- having had a diagnosis of dementia, psychotic disorder, major depressive disorder, bipolar disorder, which currently has not been treated
- having active suicidality in the past year
- currently having an untreated diagnosed sleep disorder (narcolepsy, restless leg syndrome)
- currently having have a poor physical functioning status as measured by an Eastern Cooperative Oncology Group (ECOG) score of 3 or higher and Karnofsky grade of 50 or lower
- having poor cognitive function status as measured by the Mini Mental State Examination score of 24 or less
- unable to see or hear
- at the end of life (life expectancy of less than a month)
- unwilling to change their current sleep-related habits in near future.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
Related Publications (2)
Kim Y, Ting A, Tsai TC, Carver CS. Dyadic sleep intervention for adult patients with cancer and their sleep-partner caregivers: A feasibility study. Palliat Support Care. 2024 Apr;22(2):226-235. doi: 10.1017/S1478951523000627.
PMID: 37312582DERIVEDKim Y, Ting A, Steel JL, Tsai TC. Protocol of a dyadic sleep intervention for adult patients with cancer and their sleep-partner caregivers. Contemp Clin Trials Commun. 2023 Jan 16;32:101064. doi: 10.1016/j.conctc.2023.101064. eCollection 2023 Apr.
PMID: 36704757DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Youngmee Kim, PhD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 13, 2021
First Posted
January 15, 2021
Study Start
March 14, 2021
Primary Completion
January 25, 2022
Study Completion
January 25, 2022
Last Updated
March 10, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share